Form 4 for BVS Bioventus Inc.
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0000899243-22-006658 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-16 | 2022-02-14 | BVS | Pavesio Alessandra | SVP, CSO | S - Sale | $11.99 | -433 | 119.8K | -0.4% | -$5,192 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-14 | S | D | 433 | $11.99 | 119,830 | D | — | — | (F1) Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 11, 2022 pursuant to a standing 10b5-1 instruction. |